Shanghai Xinzhi Biomed Co., Ltd.

This study tests a one-time gene therapy (BBM-H803) for adults with severe hemophilia A. The treatment uses a harmless virus to deliver a working gene so the body can produce its own clotting factor VIII, potentially reducing or stopping the need for regular factor infusions. The…

This early-stage study tests whether a new gene therapy called BBM-P002 is safe for people with Parkinson's disease. The treatment is injected directly into a specific part of the brain. The study involves 18 adults who have had Parkinson's for at least 5 years, and its main goal…